Immunoglobulin M, anti-(human death receptor 5) (human-Mus musculus clone IGM-8444 ?-chain), disulfide with human-Mus musculus clone IGM-8444 ?-chain, dimer, pentamer with immunoglobulin [102????????????????????-alanine] human-Mus musculus clone IGM-8444 J chain
Chondrosarcoma
IGM Biosciences, Inc.monoclonal_antibodyPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 89/ 100
Competitive context
10 Active assets in the Chondrosarcoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ag-120 Memorial Sloan Kettering Cancer Center | Phase 2 | B |
Azacitidine IGM Biosciences, Inc. | Phase 1/2 | CCC |
CIS-DIAMMINEDICHLOROPLATINUM II Eli Lilly and Company | Phase 1/2 | CCC |
Angiotensin-(1-7) Wake Forest University Health Sciences | Phase 2 | CCC |
Atezolizumab National Cancer Institute (NCI) | Phase 2 | CCC |
View all 24 →
Same molecule, other indications
Immunoglobulin M, anti-(human death receptor 5) (human-Mus musculus clone IGM-8444 ?-chain), disulfide with human-Mus musculus clone IGM-8444 ?-chain, dimer, pentamer with immunoglobulin [102????????????????????-alanine] human-Mus musculus clone IGM-8444 J chain is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →